Bandingkan Harga & Kinerja Jasuindo Tiga Perkasa Tbk. (JTPE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jasuindo Tiga Perkasa Tbk. dan Organon Pharma Indonesia Tbk.: Jasuindo Tiga Perkasa Tbk. diperdagangkan di Rp605 (kapitalisasi pasar 4,25 T, volume 24 jam 600,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jasuindo Tiga Perkasa Tbk. jauh lebih besar — sekitar 40,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JTPE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,25 T | 104,4 M |
Volume | 600,8 rb | — |
Lot | 6,01 rb | — |
Perputaran | 365,8 jt | — |
Harga Rata-rata | 608,85 | — |
Nilai Transaksi | 365,8 jt | — |
Harga Ekuilibrium Indikatif | 605 | — |
Volume Ekuilibrium Indikatif | 2 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jasuindo Tiga Perkasa Tbk.
PT Jasuindo Tiga Perkasa Tbk (the Company) was established based on the Notarial Deed No. 122 dated November 10, 1990 of Susanti, SH., notary in Sidoarjo, Surabaya. On the first operation conduct in general printing specialize on business form printing. On 1996 got license to involve in security printing from BOTASUPAL (an institution under State Intelegent Inst)
Selengkapnya di halaman JTPE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
